Endocrine and Reproductive Pathophysiology Foundations

Mechanisms of Endocrine Dysfunction

Hypofunction: Destruction of a gland, impaired trophic signaling, impaired synthesis, or iatrogenic suppression reduces hormone output. The compensatory upstream hormone usually rises in primary target-gland failure but is low or inappropriately normal in central disease.

Hyperfunction: Autonomous neoplasia, activating antibodies or receptors, hyperplasia, or excess exogenous hormone may elevate hormone action. A normal negative-feedback circuit usually suppresses the upstream trophic hormone. Failure of suppression can identify an upstream driver.

Hormone resistance: Adequate or elevated hormone concentrations fail to produce an expected tissue response because of receptor, post-receptor, transport, or signaling abnormalities. In type 2 diabetes, for example, insulin resistance and eventual beta-cell dysfunction coexist; hormone resistance is not synonymous with hormone deficiency (Hammer & McPhee, 2019).

Hormone chemistry changes how disease presents: Peptide hormones are stored in vesicles and signal mainly through cell-surface receptors; steroid hormones are synthesized from cholesterol, circulate substantially protein-bound, and alter transcription through intracellular receptors. Thyroid hormone is stored extracellularly in follicular colloid, then released and converted to its more active T3 form in peripheral tissues. Hormone synthesis, release, transport, conversion, receptor activity, and clearance are distinct potential points of failure.

Adrenal cortical zoning: The zona glomerulosa produces aldosterone, principally under angiotensin II and potassium control. The zona fasciculata produces cortisol in response to ACTH; the zona reticularis produces adrenal androgens. This explains why central ACTH deficiency may lower cortisol while preserving aldosterone, whereas destructive primary adrenal failure may compromise both. The medulla produces catecholamines and is anatomically adjacent but physiologically distinct.

Read the Feedback Loop Before the Laboratory Value

Thyroid axis: TRH stimulates pituitary TSH; TSH drives thyroid T4 and T3 synthesis. Low free T4 with high TSH suggests primary thyroid failure, whereas low free T4 with low or inappropriately normal TSH suggests central hypothyroidism.

Adrenal axis: CRH stimulates ACTH and cortisol production. Primary cortisol deficiency tends to elevate ACTH; central deficiency does not. Aldosterone is governed mainly by renin–angiotensin signaling and potassium, so mineralocorticoid function can remain intact in central adrenal insufficiency.

Reproductive axis: Pulsatile GnRH controls FSH and LH. The gonads produce sex steroids and inhibin, which feed back on the hypothalamus and pituitary. Gonadal failure commonly raises gonadotropins; hypothalamic or pituitary failure produces inadequate gonadotropin stimulation.

The question is whether the regulatory hormone is appropriate. A TSH within the laboratory reference interval may be inappropriately low when free T4 is deficient; a suppressed ACTH is expected during exogenous glucocorticoid exposure but cannot independently localize low cortisol without exposure history. A high FSH can be a compensatory response to ovarian steroid failure. Timing, binding proteins, treatment, and acute illness can change interpretation (Penman et al., 2023).

Suppression and stimulation are different questions: A suppression test asks whether hormone production can turn off when feedback is supplied; a stimulation test asks whether a gland has reserve when challenged. The response threshold is assay- and protocol-dependent. Dynamic tests should be chosen after assessing the basal pattern, relevant medications, pregnancy, acute illness, and the safety of delaying treatment.

Blood Glucose and Counter-Regulatory Hormones

Insulin promotes glucose uptake in muscle and adipose tissue, hepatic glycogen storage, lipogenesis, and protein synthesis; it suppresses hepatic glucose release, adipose lipolysis, and ketogenesis. Glucagon counters falling glucose by stimulating hepatic glycogenolysis and gluconeogenesis. Epinephrine further increases hepatic glucose output, limits insulin secretion, and mobilizes substrates during acute stress.

Growth hormone and cortisol act over longer time scales to limit peripheral glucose use and increase the availability of substrates for hepatic glucose production. These defenses can fail with advanced insulin deficiency, autonomic neuropathy, alcohol-related depletion of hepatic reserves, or concurrent adrenal insufficiency. Glucagon and epinephrine provide relatively rapid counter-regulation; cortisol and growth hormone contribute delayed support (Funk, 2019).

Diagnostic Interpretation: Match the Test to the Question

Time and context: Cortisol has a circadian rhythm; pregnancy changes binding proteins and physiology; acute illness can alter thyroid tests; medicines can affect hormone production, assay results, and downstream markers. A reference-range result should be interpreted against the clinical state, timing, medications, and paired regulatory hormone.

Localization: In hormone excess, decide whether the source is gland-autonomous, trophic-hormone dependent, or exogenous. In deficiency, separate gland failure from central hyposecretion. Imaging generally follows biochemical localization rather than replacing it.

Total versus free hormone: Altered concentrations of thyroid-binding globulin or cortisol-binding globulin can change total hormone measurements without proportionately changing the active free fraction. Estrogen exposure and pregnancy may alter binding; critical illness and some medications may distort immunoassays. A discordant laboratory result should prompt assessment of sampling conditions and analytical interference before labeling the patient with endocrine disease.

Clinical test sequence: First identify the syndrome and exclude immediately dangerous deterioration. Second obtain paired, appropriately timed tests to classify the feedback pattern. Third confirm abnormal function when required, and only then use imaging to localize a biochemical diagnosis. Incidental adrenal, thyroid, and pituitary imaging findings are common enough that anatomy alone cannot establish hormone hypersecretion.

Clinical Reasoning Priorities

Ambiguous axis example: A patient has low morning cortisol after several weeks of intermittent oral and injected glucocorticoid treatment. ACTH is not elevated. The pattern can reflect treatment-related hypothalamic–pituitary suppression; a coincidentally discovered adrenal nodule should not be assumed to explain cortisol deficiency. If hypotensive or severely ill, stabilize first; when stable, reconstruct exposure and use appropriately timed endocrine testing.

Resistance example: High insulin concentrations during euglycemia do not necessarily imply an insulin-producing tumor; insulin resistance can produce compensatory hyperinsulinemia. Conversely, high insulin during documented hypoglycemia is physiologically inappropriate and requires a different diagnostic pathway. Interpret a hormone against its expected target-tissue effect, not simply its absolute concentration.

High-Yield Distinctions

• Primary gland failure often produces low target hormone with elevated trophic hormone; central failure usually lacks an appropriate trophic rise.
• Hormone excess may reflect synthesis, release of preformed hormone, exogenous exposure, or target-organ autonomy; management depends on which mechanism is present.
• Treat a severely unstable endocrine syndrome as an emergency; definitive etiologic confirmation must not delay resuscitation.

Related YourDNP Guides

• Back to Pathophysiology

---

---

References

Hammer, G. D., & McPhee, S. J. (Eds.). (2019). Pathophysiology of disease: An introduction to clinical medicine (8th ed.). McGraw-Hill Education.

Penman, I. D., Ralston, S. H., Strachan, M. W. J., & Hobson, R. P. (Eds.). (2023). Davidson’s principles and practice of medicine (24th ed.). Elsevier.